| Prev Close | 150.34 |
| Day Low/High | 149.45 / 152.35 |
| 52 Wk Low/High | 119.51 / 152.47 |
| Avg Volume | 716.20K |
| Exchange | NYSE |
| Shares Outstanding | 102.30M |
| Market Cap | 15.38B |
| EPS | 7.10 |
| P/E Ratio | 20.65 |
| Div & Yield | N.A. (N.A) |
Latest News
LabCorp Exclusively Launches Sera Prognostics' PreTRM Test To Assess For Risk Of Preterm Birth
LabCorp® (NYSE: LH) today announced the nationwide availability of the PreTRM® test.
LabCorp Is Scheduled To Present At The Bank Of America Merrill Lynch 2017 Health Care Conference
LabCorp® (NYSE: LH) today announced it will participate at the Bank of America Merrill Lynch 2017 Health Care Conference.
LabCorp Completes Acquisition Of Pathology Associates Medical Laboratories
LabCorp® (NYSE:LH) has completed the acquisition of Pathology Associates Medical Laboratories (PAML) from former owners Providence Health & Services (Providence) and Catholic Health Initiatives (CHI).
LabCorp To Webcast Its Annual Meeting Of Shareholders
LabCorp® (NYSE: LH) today announced that its Annual Meeting of Shareholders will be webcast live beginning May 11, 2017 at 9:00 a.
LabCorp Enhances VistaSeq Hereditary Cancer Test Portfolio With Addition Of New Panels And New Genes That Can Be Assessed
LabCorp® (NYSE: LH) today announced a significant enhancement to its proprietary VistaSeq SM Hereditary Cancer portfolio, with ten new test panels focusing on the risk of specific hereditary cancer syndromes.
LabCorp's Acquisition Of Pathology Associates Medical Laboratories Clears Antitrust Review
LabCorp® (NYSE: LH) today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, or HSR Act, applicable to LabCorp's acquisition of Pathology Associates Medical Laboratories,...
LabCorp Completes Acquisition Of Assets Of Mount Sinai Health System Clinical Outreach Laboratories
LabCorp ® (NYSE: LH), a leading global life sciences company, has completed the previously announced acquisition of assets of the Mount Sinai Health System Clinical Outreach Laboratories.
Good, the Bad and the Ugly; What Troubles Me: Doug Kass' Views
Doug Kass shares his thoughts on Facebook, Allergan and Eli Lilly.
LabCorp To Exclusively Offer The M3 Checklist, A Multi-Condition Mental Health Screening Tool
LabCorp ® (NYSE:LH) and M-3 Information, LLC today announced the nationwide availability through LabCorp of the peer-reviewed, clinically validated M3 Checklist assessment for mental illness.
Laboratory Corporation Of America® Holdings Announces 2017 First Quarter Results And Updates 2017 Guidance
Laboratory Corporation of America ® Holdings (LabCorp ® or the "Company") (NYSE: LH) today announced results for the first quarter ended March 31, 2017, and updated 2017 guidance.
Covance To Expand Large-Molecule Development Capabilities In The UK
Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH), a leading global life sciences company, announced today that its Covance Drug Development (Covance) business will expand its biopharmaceutical...
Conversion Right Triggered For LabCorp's Zero Coupon Convertible Subordinated Notes Due 2021
Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) announced today that its Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) may be converted as set forth below.
LabCorp Commends Reps. Dr. Bucshon, DeGette For Releasing Bipartisan Discussion Draft Of the Diagnostic Accuracy And Innovation Act (DAIA)
Laboratory Corporation of America® Holdings (LabCorp®) (NYSE:LH), a leading global life sciences company, today issued the following statement regarding a discussion draft of the Diagnostic Accuracy and Innovation...
Gary Huff (Photo: Business Wire)
Laboratory Corporation of America® Holdings (LabCorp®) (NYSE:LH), a leading global life sciences company, today announced that Gary Huff is being promoted to CEO of LabCorp Diagnostics, one of the company's two...
LabCorp's Zero Coupon Convertible Subordinated Notes Due 2021 To Accrue Contingent Interest
Laboratory Corporation of America ® Holdings (LabCorp ®) (NYSE: LH) announced today that for the period of March 12, 2017 to September 11, 2017, its Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon...
LabCorp Is Scheduled To Present At The 2017 Barclays Global Healthcare Conference
Laboratory Corporation of America ® Holdings (LabCorp ®) (NYSE: LH) today announced it will participate at the 2017 Barclays Global Healthcare Conference.
LabCorp Is Scheduled To Present At The 38th Annual Raymond James Institutional Investors Conference
Laboratory Corporation of America ® Holdings (LabCorp ®) (NYSE: LH) today announced it will participate at the 38 th Annual Raymond James Institutional Investors Conference.
LabCorp To Acquire Pathology Associates Medical Laboratories From Providence Health & Services And Catholic Health Initiatives
Laboratory Corporation of America ® Holdings (LabCorp ®) (NYSE:LH), Providence Health & Services (Providence) and Catholic Health Initiatives (CHI), today announced that they have entered into a...
Amid M&A Buzz, LabCorp CEO Says Deal Pipeline 'Very Healthy'
LabCorp's earnings call took place on the heels of a media report earlier this month that the company was in discussions to buy Pharmaceutical Product Development.
Laboratory Corporation Of America® Holdings Announces Record 2016 Fourth Quarter And Full Year Results And Provides 2017 Guidance
Laboratory Corporation of America ® Holdings (LabCorp ® or the "Company") (NYSE:LH) today announced results for the fourth quarter and year ended December 31, 2016, and provided 2017 guidance.
LabCorp To Acquire Assets Of Mount Sinai Health System Clinical Outreach Laboratories
Laboratory Corporation of America ® Holdings (LabCorp ®) (NYSE: LH), a world leading life sciences company, and the Mount Sinai Health System (Mount Sinai), one of the largest health systems in metropolitan New...
LabCorp Is Scheduled To Present At The 35th Annual J.P. Morgan Healthcare Conference
Laboratory Corporation of America ® Holdings (LabCorp ®) (NYSE: LH) today announced it will participate at the 35 th Annual J.
Leading Genetic Testing Companies Join Forces To Launch The Coalition For Access To Prenatal Screening
Coalition aims to make noninvasive prenatal testing easily accessible to all pregnant women
Conversion Right Triggered For LabCorp's Zero Coupon Convertible Subordinated Notes Due 2021
Laboratory Corporation of America ® Holdings (LabCorp ®) (NYSE: LH) announced today that its Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) may be converted as set forth below.
INC Research Holdings Seen as Likely LabCorp. Takeover Target
The contract research organization has been viewed as a logical takeout target of LabCorp. for some time now.
Computerworld Names Covance's Dimitris Agrafiotis A Premier 100 Technology Leader
Laboratory Corporation of America ® Holdings (LabCorp ®) (NYSE: LH), the world's leading healthcare diagnostics company, is proud to announce that IDG's Computerworld recently recognized Dimitris Agrafiotis,...
LabCorp Is Scheduled To Present At The 2016 Credit Suisse Healthcare Conference
Laboratory Corporation of America ® Holdings (LabCorp ®) (NYSE: LH) today announced it will participate at the 2016 Credit Suisse Healthcare Conference.
